Researchers investigate link between COVID-19 and increased risk of blood clot formation news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
Why are some Covid-19 survivors at risk of blood clot? Thursday, April 15, 2021 IWK Bureau
People who have recovered from Covid-19, especially those with pre-existing cardiovascular conditions, may be at risk of developing blood clots due to a lingering and overactive immune response, according to a study.
The study, led by researchers from the Nanyang Technological University in Singapore, found that recovered Covid-19 patients had twice the normal number of circulating endothelial cells (CECs) that had been shed from damaged blood vessel walls.
The elevated levels of CECs indicate that blood vessel injury is still apparent after recovering from viral infection.
Recovering Covid patients more at risk of developing blood clots heraldscotland.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from heraldscotland.com Daily Mail and Mail on Sunday newspapers.
SINGAPORE - People who have recovered from Covid-19, regardless of the severity of their disease, may be at risk of developing blood clots due to an overactive immune system, according to a study by local scientists.
Blood clots in major arteries, especially those which are linked to vital organs, can increase a person s risk of heart attack, stroke or organ failure.
Blood samples from 30 patients who had recovered from mild, moderate and severe Covid-19 were collected a month after they had been discharged from the hospital.
All of them were found to have blood vessel damage, possibly arising from a lingering immune response, which could trigger the formation of blood clots.
People who have recovered from COVID-19, especially those with pre-existing cardiovascular conditions, may be at risk of developing blood clots due to a lingering and overactive immune response, according to a study led by Nanyang Technological University, Singapore (NTU) scientists.